Volume : 09, Issue : 10, October – 2022

Title:

58.INTRAOPERATIVE REDOSING OF SURGICAL ANTIBIOTIC PROPHYLAXIS IN ADDITION TO PREOPERATIVE PROPHYLAXIS VERSUS SINGLE-DOSE PROPHYLAXIS FOR THE PREVENTION OF SURGICAL SITE INFECTION
‬

Authors :

Dr Muhammad Uzair, Dr Muhammad Arsal, Dr Maryam khan

Abstract :

Objective: The aim of this study was to determine the effect of preoperative surgical antibiotic prophylaxis (SAP) with additional intraoperative redosing compared to single-dose preoperative surgical antibiotic prophylaxis on the incidence of surgical site infections (SSI).
Summary Background Data: Preoperative SAP is standard care for the prevention of SSI. During long surgical procedures, additional intraoperative redosing of SAP is advised, but there is great variability in redosing strategies and compliance rates.
Methods: We performed a systematic search of MEDLINE (PubMed), Embase, CINAHL and CENTRAL on June 25th, 2021 according to PROSPERO registration CRD42021229035. We included studies that compared the effect of preoperative SAP with additional intraoperative redosing to single dose preoperative SAP (no redosing) on SSI incidence in patients undergoing any type of surgery. Two researchers performed data appraisal and extraction of summary data independently. Meta-analyses were stratified per study type.
Results: We included 2 randomized controlled trials (RCT) and 8 cohort studies comprising of 9470 patients. Pooled odds ratios for SSI in patients receiving intraoperative redosing compared to those without redosing were 0.47 (95% CI: 0.19–1.16. I2 ¼ 36%) for RCTs and 0.55 (95% CI: 0.38–0.79, I2 ¼ 56%) for observational cohorts. There was considerable clinical heterogeneity among antibiotics used and redosing protocols. GRADE-assessment showed overall low certainty of evidence.
Conclusion: Intraoperative redosing of SAP may reduce incidence of SSI compared to a single dose preoperative SAP in any type of surgery, based on studies with considerable heterogeneity of antibiotic regimens and redosing protocols.
Keywords: anesthesia, antibiotics, meta-analysis, prevention, surgery, surgical site infections

Cite This Article:

References:

Arabic References

1. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence surveyof health care-associated infections. N Engl J Med. 2014;370:1198–1208.
2. Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemichealth-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–241.
3. Griskevicˇien¼ J. European Centre for Disease Prevention and Control. Surveillance of surgical site infections in Europe 2010-2011. Stockholm: ECDC; 2013.
4. de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidenceand impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37:387–397.
5. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines forantimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70:195– 283.
6. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines forClostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66:987–994.
7. Global guidelines for the prevention of surgical site infection, second edition.Geneva: World Health Organization; 2018.
8. Berrios-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for DiseaseControl and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152:784–791.
9. Excellence NIfHaC, 2020. Available at: https://www.nice.org.uk/guidance/ ng125. Accessed July 26, 2020.
10. de Jonge SW, Gans SL, Atema JJ, et al. Timing of preoperative antibioticprophylaxis in 54,552 patients and the risk of surgical site infection: a systematic review and meta-analysis. Medicine (Baltimore). 2017;96:e6903.
11. Goldmann DA, Hopkins CC, Karchmer AW, et al. Cephalothin prophylaxis incardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg. 1977;73:470–479.
12. Zelenitsky SA, Calic D, Arora RC, et al. Antimicrobial prophylaxis forpatients undergoing cardiac surgery: intraoperative cefazolin concentrations and sternal wound infections. AntimicrobAgentsChemother. 2018;62:e0136018.
13. Zelenitsky SA, Ariano RE, Harding GK, et al. Antibiotic pharmacodynamicsin surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother. 2002;46:3026– 3030.
14. de Jonge SW, Boldingh QJJ, Solomkin JS, et al. Effect of postoperativecontinuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20:1182–1192.
15. Ohge H, Takesue Y, Yokoyama T, et al. An additional dose of cefazolin forintraoperative prophylaxis. Surg Today. 1999;29:1233–1236.
16. DiPiro JT, Vallner JJ, Bowden TA Jr, et al. Intraoperative serum and tissueactivity of cefazolin and cefoxitin. Arch Surg. 1985;120:829–832.
17. Kasatpibal N, Whitney JD, Dellinger EP, et al. Failure to redose antibioticprophylaxis in long surgery increases risk of surgical site infection. Surg Infect (Larchmt). 2017;18:474–484.
18. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin andrisk for surgical site infection in cardiac surgery. Emerg Infect Dis. 2001;7:828–831.
19. Excellence NIfHaC. Surgical site infections: prevention and treatment – fullguidance. National Institute for Health and Clinical Excellence; 2008.
20. Bratzler DW, Houck PM, Surgical Infection Prevention Guideline Writers W.Antimicrobial prophylaxis for surgery: an advisory statement from the
National Surgical Infection Prevention Project. Am J Surg. 2005;189:395– 404.
21. veiligheidsprogramma V. Praktijkgids ‘Voorkomen van wondinfecties na eenoperatie’. 2009.
22. Steinberg JP, Braun BI, Hellinger WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg. 2009;250:10–16.
23. de Jonge SW, Boldingh QJJ, Koch AH, et al. Timing of preoperative antibioticprophylaxis and surgical site infection: TAPAS, an observational cohort study. Ann Surg. 2021;274:e308–e314.
24. Moher D, Liberati A, Tetzlaff J, et al., Group P. Preferred reporting items forsystematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.
25. Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan-a web and mobile appfor systematic reviews. Syst Rev. 2016;5:210.
26. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention ofsurgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278. quiz 79-80.
27. Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratioin cohort studies of common outcomes. JAMA. 1998;280:1690–1691.
28. The selection and use of essential medicines: report of the WHO ExpertCommittee on Selection and Use of Essential Medicines, 2019 (including the 21st WHO Model List of Essential Medicines and the 7th WHO Model List of Essential Medicines for Children). 2019.
29. Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing riskof bias in randomised trials. BMJ. 2019;366:l4898.
30. Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing riskof bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
31. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detectedby a simple, graphical test. BMJ. 1997;315:629–634.
32. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. IntroductionGRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–394.
33. Colombo MZ G, Negri L, Scalambrino S, et al. A randomized comparison ofone-dose versus two-dose antibiotic prophylaxis in gynaecologic surgery lasting over two hours. Italian J Gynaecol Obstet. 1998;10:9–15.
34. Scher KS. Studies on the duration of antibiotic administration for surgicalprophylaxis. Am Surg. 1997;63:59–62.
35. Bertschi D, Weber WP, Zeindler J, et al. Antimicrobial prophylaxis redosingreduces surgical site infection risk in prolonged duration surgery irrespective of its timing. World J Surg. 2019;43:2420–2425.
36. Morita S, Nishisho I, Nomura T, et al. The significance of the intraoperativerepeated dosing of antimicrobials for preventing surgical wound infection in colorectal surgery. Surg Today. 2005;35:732–738.
37. Zhang Y, Mahar AL, Edgar B, et al. Length of surgery and intra-operative bestpractices determine surgical site infection risk in operations of prolonged surgery. Can J Infect Control. 2015;30:158–164.
38. Zhang X, Li T, Li Y, et al. Protective effect of intraoperative re-dose ofprophylactic antibiotics on surgical site infection in diabetic patients: a retrospective cohort study. Ann Transl Med. 2019;7:96.